Spots Global Cancer Trial Database for lung disease
Every month we try and update this database with for lung disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC | NCT03085069 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Lung Disease Respiratory Tra... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 | 18 Years - 80 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | NCT04614103 | Metastatic Non ... | LN-145 LN-145 | 18 Years - 70 Years | Iovance Biotherapeutics, Inc. | |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | NCT05361174 | Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm... | IOV-4001 | 18 Years - | Iovance Biotherapeutics, Inc. | |
| Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease. | NCT02168036 | Lung Disease Inflammation Lung Cancer Sarcoidosis | 18 Years - 70 Years | Weill Medical College of Cornell University | ||
| Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis | NCT02913365 | Hemoptysis Haemoptysis Lung Disease Pneumonia Tuberculosis Bronchiectasis Respiratory Tra... Respiratory Tra... Bronchitis Mycobacterium I... Bronchial Disea... Pulmonary Hemor... Signs and Sympt... Signs and Sympt... Pathologic Proc... Mycosis Hemorrhage Lung Cancer Pulmonary Embol... Arteriovenous F... | 18 Years - | Université de Sherbrooke | ||
| Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases | NCT00366509 | Pulmonary Disea... Oropharyngeal D... Lymphangioleiom... Pulmonary Fibro... Asthma Sarcoidosis | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung | NCT02466568 | Lung Cancer Adenocarcinoma ... | Nivolumab GM.CD40L Vaccin... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC | NCT03085069 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Lung Disease Respiratory Tra... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 | 18 Years - 80 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Study of the Disease Process of Lymphangioleiomyomatosis | NCT00001465 | Lung Disease Pneumothorax Tuberous Sclero... Lymphangioleiom... | Toshibia Aquili... | 16 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis | NCT02965300 | Lung Neoplasm Lung Disease | 18 Years - 85 Years | Chinese PLA General Hospital | ||
| Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease. | NCT02168036 | Lung Disease Inflammation Lung Cancer Sarcoidosis | 18 Years - 70 Years | Weill Medical College of Cornell University | ||
| Role of Genetic Factors in the Development of Lung Disease | NCT00001532 | Cystic Fibrosis Pulmonary Fibro... Tuberous Sclero... Asthma Pulmonary Sarco... | 2 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) | NCT05973773 | Advanced or Met... | TAS6417 | 18 Years - | Taiho Oncology, Inc. | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC | NCT03085069 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Lung Disease Respiratory Tra... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 | 18 Years - 80 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies | NCT00923520 | Renal Cell Carc... Breast Cancer Colon Cancer Lung Cancer Non-Hodgkin Lym... | DMS 612 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) | NCT05973773 | Advanced or Met... | TAS6417 | 18 Years - | Taiho Oncology, Inc. | |
| Natrecor in Pulmonary Hypertension | NCT00075179 | Pulmonary Hyper... Cancer Lung Disease Cardiothoracic ... | Nesiritide (Nat... Right Heart Cat... | 18 Years - 85 Years | M.D. Anderson Cancer Center | |
| Natrecor in Pulmonary Hypertension | NCT00075179 | Pulmonary Hyper... Cancer Lung Disease Cardiothoracic ... | Nesiritide (Nat... Right Heart Cat... | 18 Years - 85 Years | M.D. Anderson Cancer Center | |
| Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) | NCT03406715 | Small Cell Lung... Lung Cancer Relapsed Small ... | Nivolumab Ipilimumab Dendritic Cell ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Minimally Invasive Endoscopy in Diffuse Lung Disease | NCT00934778 | Lung Disease Lung Cancer | Confocal micros... | 16 Years - | Royal Brompton & Harefield NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
